AEW has completed a strategic investment in the Netherlands with the acquisition of a high-quality life science asset in Nijmegen on behalf of a strategy for French retail investors. This sale-leaseback transaction with Symeres, a major player in pharmaceutical research and manufacturing, marks a significant step in strengthening the fund’s presence in the European market.
Antoine Barbier, head of AEW Patrimoine, said, “This investment marks our entry into the Dutch life science market. It allows us to build strategic exposure to this increasingly attractive real estate typology for our clients, while strengthening the geographical diversification and granularity of our fund’s portfolio in Europe.”
The approximately 60,278-square-foot asset comprises two interconnected buildings, offering an optimal allocation of 80 percent laboratory space and 20 percent office space. Symeres, which has owned and occupied the site since 2006 when it originally developed the as
